Neoleukin Therapeutics

-$0.15 (-2.03%) Today

$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NLTX and other ETFs, options, and stocks.

About NLTX

Neoleukin Therapeutics, Inc. operates as a biopharmaceutical company, which computational methods to design de novo protein therapeutics. The firm address significant medical needs in oncology, inflammation, and autoimmunity.

CEO

Jonathan G. Drachman

Employees

Headquarters

Seattle, Washington

Founded

2003

NLTX Key Statistics

Market Cap

459.87M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

150.02K

High Today

$7.53

Low Today

$7.21

Open Price

$7.42

Volume

93.48K

52 Week High

$17.95

52 Week Low

$7.10

Analyst Ratings

100%

of 6 ratings

Buy

100%

Hold

Sell

NLTX Earnings

-$0.37

-$0.25

-$0.12

$0.00

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Estimated

— per share

Actual

Expected Aug 9, Pre-Market